A new therapeutic approach to KRAS mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition

Translational Lung Cancer Research 2026 Open access

Read full text
Authors: Mitchell S. von Itzstein, David E. Gerber
DOI: 10.21037/tlcr-2025-1-1493
Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Protein Kinase Regulation and GTPase Signaling Nuclear Structure and Function

Publication details

Journal / source
Translational Lung Cancer Research
Volume
15
Issue
2
Pages
44–44
Publication date
1 February 2026
Language
EN